Market Place
Sourcing Support
Biofrontera Launches FDA-Approved RhodoLED® XL Red Light Source
24 Jun 2024 //
GLOBENEWSWIRE
Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion U.S. Patent
06 Sep 2022 //
GLOBENEWSWIRE
Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK
12 Jun 2020 //
EXPRESS PHARMA
Sun Pharma Plans to Present Clinical Insights from 25 Data Abstracts
10 Jun 2020 //
PRNEWSWIRE
Alnylam Announces Approval of GIVLAARI® (givosiran) in the European Union
03 Mar 2020 //
BUSINESSWIRE
‘Groundbreaking’ new brain cancer treatment available
13 May 2019 //
PHARMA TIMES
Alnylam shores up enthusiasm for givosiran with early dataset
07 Feb 2019 //
ENDPTS
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
16 Oct 2018 //
XCONOMY
Sun Pharma`s subsidiary files patent infringement suit against Biofrontera
12 Jul 2018 //
ECONOMIC TIMES
NICE backs use of dye for brain tumour removal
11 Jul 2018 //
PHARMA TIMES
Biofrontera files for IPO to run skin cancer clinical trials
15 Jan 2018 //
FIERCE BIOTECH
Chugai Pharma to market SBI Pharma`s Alaglio Granule 1.5g in Japan
14 Mar 2017 //
PHARMABIZ
How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US
07 Jan 2017 //
ECONOMIC TIMES
NZ gets drug that glows brain tumour
21 Sep 2015 //
BIOSPECTRUM ASIA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.